ICU Medical (NASDAQ:ICUI) Lowered to Hold Rating by StockNews.com

ICU Medical (NASDAQ:ICUI) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Thursday.

Several other equities research analysts have also commented on the stock. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, December 11th. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $168.67.

ICU Medical Stock Performance

Shares of ICUI traded down $4.43 during trading hours on Thursday, hitting $144.28. The stock had a trading volume of 171,682 shares, compared to its average volume of 256,501. The firm has a market capitalization of $3.54 billion, a PE ratio of -31.57 and a beta of 0.73. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical has a 12 month low of $93.36 and a 12 month high of $196.26. The stock has a fifty day moving average price of $154.89 and a 200 day moving average price of $164.01.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,262,119.64. This represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 6.70% of the company’s stock.

Institutional Trading of ICU Medical

Institutional investors and hedge funds have recently modified their holdings of the company. Vise Technologies Inc. boosted its holdings in ICU Medical by 7.1% in the 4th quarter. Vise Technologies Inc. now owns 2,649 shares of the medical instruments supplier’s stock worth $411,000 after buying an additional 176 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in ICU Medical by 20.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 51,531 shares of the medical instruments supplier’s stock valued at $7,996,000 after acquiring an additional 8,789 shares during the period. Woodline Partners LP lifted its position in shares of ICU Medical by 4.5% in the fourth quarter. Woodline Partners LP now owns 122,239 shares of the medical instruments supplier’s stock valued at $18,968,000 after acquiring an additional 5,300 shares in the last quarter. Squarepoint Ops LLC bought a new position in shares of ICU Medical in the fourth quarter worth about $3,236,000. Finally, Tidal Investments LLC purchased a new stake in shares of ICU Medical during the fourth quarter worth about $342,000. 96.10% of the stock is currently owned by institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.